Plasma medications are produced from human blood plasma (plasma). Plasma can be obtained from administration of whole blood (recovered plasma) or apheresis procedures (plasma source). The source is plasma a wide range of medicinal therapies products used for treatment and the prevention of various treatment-causing injuries and diseases often associated with a protein deficiency state. Convalescent Plasma Therapy (CP), a classic adaptive immunotherapy, has been used in the prevention and treatment of many infectious diseases for over a century. In the past two decades, CP therapy has been successfully used in the treatment of the 2009 SARS, MERS and H1N1 pandemic with satisfactory efficacy and safety. In 2014, the World Health Organization (WHO) recommended the use of convalescent plasma therapy for the treatment of patients with antibody-rich plasma in those recovering from Ebola virus disease.
Numerous clinical trials are also being held to evaluate the safety and efficacy of convalescent plasma, and the FDA has also approved a number of individual emergencies (eINDs) for emergencies.
Get Full TOC, Tables and Figures of Market Report @ https://www.databridgemarketresearch.com/covid-19-resources/covid-19-impact-on-plasma-therapy-in-the-healthcare-industry
The global plasma therapy market is expected to reach US$384.94 million in 2024, witnessing growth at a CAGR of 7.24%, over the period 2020-2024. Factors such as rising healthcare expenditure, increasing occurrences of orthopedic disorders, growing geriatric population, rising prevalence of chronic diseases, expanding urbanization and growing preference towards non-surgical procedures are expected to drive the market. The growth of the market would be challenged by severe side effects of plasma therapy and barriers to implementation. A few notable trends may include escalating androgenic alopecia patients, huge demand due to coronavirus, better healthcare provision in developed countries and advancements in technology.
The market research study carried out in global Plasma Therapy Market business report helps to recognize the various drivers and restraints impacting the market during the forecast period. Choosing market research report is very essential for the business growth as it helps with the better decision making, enhancing revenue generation, prioritizing market goals and results in profitable business. Evaluations about the CAGR value variations for specific forecast period, market drivers, market restraints, and competitive strategies are measured in this report. Granular market information combined in this persuasive Plasma Therapy Market report will be helpful to Healthcare industry to take competent business decisions.
Global Cold Plasma Market, By Regime Type (Low Pressure, Atmospheric Pressure), Technology (Remote Treatment Direct Treatment, Electrode Contact), Industry (Textile, Polymer And Plastic, Electronics And Semiconductor, Food & Agriculture, Medical), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Cold plasma market is segmented on the basis of regime type, technology and industry. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
Based on regime type, the cold plasma market is segmented into low pressure and atmospheric pressure.
Cold plasma market has also been segmented based on the technology into remote treatment, direct treatment and electrode contact.
Based on industry, the cold plasma market is segmented into textile, polymer and plastic, electronics and semiconductor, food & agriculture and medical.
Market Analysis: Global Plasma Therapy Market
Global plasma therapy market is registering a healthy CAGR of 15.7% in the forecast period of 2019-2026. This rise in the market value can be attributed to the growth in the use of planet rich plasma for the treatment of various diseases that drives the growth of the industry and increasing incidents of sports injuries.
The global plasma therapy market has been segmented into type, source, application, and end user.
On the basis of type, the global plasma therapymarket is divided into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin, and Leukocyte-Rich Fibrin.Pure platelet-rich plasma (PRP) therapy is anticipated to garner the largest market share owing to its effectiveness over other products.
By source, the global plasma therapy market is classified into autologous and allogenic. Growing adoption of autologous source of plasma therapy for healing bones and other such tissues is expected to contribute to the largest market share of the autologous segment.
Based upon the application, the market is categorized into orthopedic, dermatology, cardiac muscle injury, and others. The orthopaedic segment is anticipated to hold the largest market share owing to high adoption of plasma therapy for the treatment of orthopaedic disorders.
The market on the basis of end user is segmented into hospitals& clinics, research institutions, and others. Since, hospitals are the primary care centers, they are expected to hold a major market share.
• Platelet-rich Plasma (PRP) Manufacturers and Suppliers
• Plasma Therapy Service/Equipment Providers and Distributors
• End Users (Hospitals & Clinics and Medical Research Institutes)
• Government Bodies & Regulating Authorities